Relative to prescription medication transfer and availability
Impact
The proposed amendments in H774 would modify Chapter 94C of the General Laws, particularly concerning how prescriptions can be managed in chain pharmacies. This includes a clear definition of a 'chain pharmacist' and the conditions under which prescriptions can be transferred. The implications of this legislation would provide a more efficient approach to prescription management in Massachusetts, potentially reducing the burden on patients needing immediate medication refills and supporting continuity of care.
Summary
House Bill 774 aims to enhance the transfer and availability of prescription medications by allowing chain pharmacists to transfer prescriptions within the same pharmacy chain. This legislative change is intended to improve patient access to necessary medications when a particular pharmacy runs out of stock. By permitting these transfers, the bill seeks to streamline the process of obtaining prescriptions, ultimately benefiting patients who may face delays or complications when their required medications are unavailable at their primary pharmacy.
Contention
While the bill is framed as a means to enhance patient access to medications, opposition may stem from concerns regarding patient privacy and the consent process involved in such transfers. Some advocates might argue that more stringent regulations are necessary to safeguard patients' interests in situations where their prescriptions are transferred without their explicit awareness. Additionally, the bill could raise questions about the adequacy of stock at pharmacies and how this might impact pricing or availability of certain medications not commonly stocked in all locations.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a sixty-day (60) supply may be dispensed at any one time.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a ninety-day (90) supply may be dispensed at any one time.